Skip to main content
. 2017 Sep 25;40(5):1511–1519. doi: 10.3892/ijmm.2017.3152

Figure 3.

Figure 3

Transient receptor potential channel 1 (TRPC1) expression was downregulated in podocyte injury. (A) Predicted miR-135a target TRPC1 3′ untranslated region (UTR) in human and mouse species. (B) The protein level of TRPC1 was downregulated in the glomeruli isolated from BALB/c mice treated with adriamycin (ADR) in a time-dependent manner. (C) Quantitative analysis of the results of (B). (D) TRPC1 expression was inhibited in cultured MPC5 cells treated with ADR (5 μg/ml, 24 h) and transforming growth factor (TGF)-β (5 ng/ml, 24 h). (E) Quantitative analysis of the results of (D). *P<0.05 and **P<0.01 indicate statistically significant and highly statistically significant differences, respectively, compared with the control group.